Clinical research has shown Tirzepatide can lead to more substantial weight loss compared to many traditional medications, particularly when combined with nutrition counseling, exercise, and long-term lifestyle changes
Tirzepatide, a dual GIP/GLP-1 receptor agonist, is also available in oral and sublingual compounded formats
0.25mg, then gradually increases over 8 weeks to 1mg
Tirzepatide, a novel peptide therapy, is administered by our experienced medical team to help patients achieve healthier and sustainable results for medical weight loss
You might find that you have more energy, feel better about yourself, and experience less mental fatigue or hopelessness